391-405 of 894
Radium-223’s Potential Quality of Life Benefits for mCRPC Patients
Project Oncology®Radium-223’s Potential Quality of Life Benefits for mCRPC Patients
Treatment Selection Strategies for Metastatic Breast Cancer Patients
Project Oncology®Treatment Selection Strategies for Metastatic Breast Cancer Patients
Sarah Sammons, MD
Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Project Oncology®Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Sarah Sammons, MD
Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Project Oncology®Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Sarah Sammons, MD
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
Clinician's RoundtableHow CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
Jennifer Caudle, DO, FACOFP
A. Mark Fendrick, MD
Breast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
Project Oncology®Breast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
Basak Dogan, MD
- advertisement
Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
Project Oncology®Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
Gareth Morgan, MD
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Project Oncology®Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Betsy O'Donnell, MD
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Project Oncology®From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Betsy O'Donnell, MD
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Project Oncology®Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Betsy O'Donnell, MD
Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
Project Oncology®Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
Morie Gertz, MD, MACP
T-Cell Characteristics: Key Players in Bispecific Antibody Treatment Success
Project Oncology®T-Cell Characteristics: Key Players in Bispecific Antibody Treatment Success
- advertisement
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Project Oncology®Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Jody Takemoto, PhD, MEd
David Braun
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Project Oncology®Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Munir Ghesani, MD
Enhancing HCC Outcomes Through Multidisciplinary Care
Project Oncology®Enhancing HCC Outcomes Through Multidisciplinary Care
Charles Turck, PharmD, BCPS, BCCCP
Hannah Lee, MD
